BR112014001538A2 - composições farmacêuticas compreendendo 4-bromo-n-(imidazolidin-2-ilideno)-1h-benzimidazol-5-amina para tratamento de doenças retinais - Google Patents
composições farmacêuticas compreendendo 4-bromo-n-(imidazolidin-2-ilideno)-1h-benzimidazol-5-amina para tratamento de doenças retinaisInfo
- Publication number
- BR112014001538A2 BR112014001538A2 BR112014001538A BR112014001538A BR112014001538A2 BR 112014001538 A2 BR112014001538 A2 BR 112014001538A2 BR 112014001538 A BR112014001538 A BR 112014001538A BR 112014001538 A BR112014001538 A BR 112014001538A BR 112014001538 A2 BR112014001538 A2 BR 112014001538A2
- Authority
- BR
- Brazil
- Prior art keywords
- imidazolidin
- ylidene
- amine
- benzimidazol
- bromo
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 4
- 208000017442 Retinal disease Diseases 0.000 title abstract 3
- 235000020945 retinal Nutrition 0.000 abstract 3
- 230000002207 retinal effect Effects 0.000 abstract 3
- 230000004112 neuroprotection Effects 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
- 229910052794 bromium Inorganic materials 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 150000003726 retinal derivatives Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Ophthalmology & Optometry (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161510536P | 2011-07-22 | 2011-07-22 | |
| US201161510743P | 2011-07-22 | 2011-07-22 | |
| PCT/US2012/047777 WO2013016252A1 (en) | 2011-07-22 | 2012-07-22 | Pharmaceutical compositions comprising 4-bromo-n-(imidazolidin-2-ylidene)-1h-benzimidazol-5-amine for treating retinal diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014001538A2 true BR112014001538A2 (pt) | 2017-02-14 |
Family
ID=46599017
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014001538A BR112014001538A2 (pt) | 2011-07-22 | 2012-07-22 | composições farmacêuticas compreendendo 4-bromo-n-(imidazolidin-2-ilideno)-1h-benzimidazol-5-amina para tratamento de doenças retinais |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20130046003A1 (https=) |
| EP (1) | EP2734202A1 (https=) |
| JP (1) | JP2014521648A (https=) |
| KR (1) | KR20140097106A (https=) |
| CN (1) | CN103826631A (https=) |
| AU (1) | AU2012287062A1 (https=) |
| BR (1) | BR112014001538A2 (https=) |
| CA (1) | CA2842756A1 (https=) |
| IL (1) | IL230582A0 (https=) |
| MX (1) | MX2014000870A (https=) |
| RU (1) | RU2014106328A (https=) |
| WO (1) | WO2013016252A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10752593B2 (en) | 2018-12-28 | 2020-08-25 | Endogena Therapeutics, Inc. | Compounds for use as therapeutically active substances in the treatment of retinal diseases |
| US10807973B2 (en) | 2018-12-28 | 2020-10-20 | Endogena Therapeutics, Inc. | Compounds for use as therapeutically active substances in the treatment of retinal diseases |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0775134A4 (en) | 1994-08-04 | 1997-08-13 | Synaptic Pharma Corp | NEW BENZIMIDAZOLE DERIVATIVES |
| AU4582797A (en) | 1996-09-13 | 1998-04-02 | Regents Of The University Of California, The | Methods for treatment of retinal diseases |
| US6495583B1 (en) | 1997-03-25 | 2002-12-17 | Synaptic Pharmaceutical Corporation | Benzimidazole derivatives |
| US20010049369A1 (en) * | 2000-02-10 | 2001-12-06 | Jablonski Monica M. | Brimonidine compositions and methods for retinal degeneration |
| AU2002248284A1 (en) * | 2000-11-01 | 2002-08-06 | Allergan, Inc. | Compositions for treatment of ocular neovascularization |
| US20020198209A1 (en) | 2001-05-03 | 2002-12-26 | Allergan Sales Inc. | Compositions having enhanced pharmacokinetic characteristics |
| US20050244463A1 (en) * | 2004-04-30 | 2005-11-03 | Allergan, Inc. | Sustained release intraocular implants and methods for treating ocular vasculopathies |
| US20100028266A1 (en) * | 2008-08-01 | 2010-02-04 | Alpha Synergy Development. Inc. | Composition and methods for treating allergic response |
| BR112012018154A2 (pt) * | 2010-01-21 | 2016-04-05 | Allergan Inc | agonista alfa-2 adrenérgico tendo longa duração do efeito de redução da pressão intraocular |
-
2012
- 2012-07-20 US US13/555,070 patent/US20130046003A1/en not_active Abandoned
- 2012-07-22 CN CN201280046184.4A patent/CN103826631A/zh active Pending
- 2012-07-22 AU AU2012287062A patent/AU2012287062A1/en not_active Abandoned
- 2012-07-22 KR KR1020147004520A patent/KR20140097106A/ko not_active Withdrawn
- 2012-07-22 JP JP2014522917A patent/JP2014521648A/ja active Pending
- 2012-07-22 EP EP12741226.0A patent/EP2734202A1/en not_active Withdrawn
- 2012-07-22 WO PCT/US2012/047777 patent/WO2013016252A1/en not_active Ceased
- 2012-07-22 MX MX2014000870A patent/MX2014000870A/es not_active Application Discontinuation
- 2012-07-22 BR BR112014001538A patent/BR112014001538A2/pt not_active IP Right Cessation
- 2012-07-22 RU RU2014106328/15A patent/RU2014106328A/ru not_active Application Discontinuation
- 2012-07-22 CA CA2842756A patent/CA2842756A1/en not_active Abandoned
-
2014
- 2014-01-22 IL IL230582A patent/IL230582A0/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20130046003A1 (en) | 2013-02-21 |
| IL230582A0 (en) | 2014-03-31 |
| KR20140097106A (ko) | 2014-08-06 |
| CN103826631A (zh) | 2014-05-28 |
| RU2014106328A (ru) | 2015-08-27 |
| JP2014521648A (ja) | 2014-08-28 |
| MX2014000870A (es) | 2014-06-23 |
| AU2012287062A1 (en) | 2014-02-27 |
| EP2734202A1 (en) | 2014-05-28 |
| CA2842756A1 (en) | 2013-01-31 |
| WO2013016252A1 (en) | 2013-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112014008789A2 (pt) | prevenção e tratamento de condições oculares | |
| BR112015007778A2 (pt) | profármacos neutralizantes de vegf para o tratamento de condições oculares | |
| BR112014031394A2 (pt) | composições e métodos para absorção transmucosa | |
| BR112014028633A8 (pt) | tratamento de amd usando sflt-1 de aav | |
| BR112015003188A2 (pt) | Composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
| BR112015029512A2 (pt) | derivados de pirazolopirrolidina e seu uso no tratamento de doenças | |
| BR112015029491A2 (pt) | derivados de imidazopirrolidinona e seu uso no tratamento de doença | |
| EA201270221A1 (ru) | Лечение болезни крона с применением лаквинимода | |
| BR112015022197A8 (pt) | uso de um composto para fabricação de um medicamento ou composição farmacêutica para o tratamento de cataplexia | |
| BR112012015499A2 (pt) | método de tratamento de fibrilação atrial | |
| WO2014205229A8 (en) | Use of high dose pridopidine for treating huntington's disease | |
| EA201590655A1 (ru) | Комбинация лахинимода и придопидина для лечения нейродегенеративных нарушений | |
| BR112015000136A2 (pt) | fibra alimentar para uso no tratamento de um efeito colateral gastrintestinal de uma nutrição ou medicamento | |
| BR112015010396A2 (pt) | terapia de combinação | |
| BR112014030813A2 (pt) | tratamento de efeitos colaterais de desordens motoras e de movimento associadas com tratamentos de doenças parkinson | |
| BR102013003570A8 (pt) | Composições de plasma rico em plaquetas | |
| BR112014008036A2 (pt) | tratamento de rinite | |
| BR112012006010A2 (pt) | composto de glicina | |
| BR112014010376A2 (pt) | medicamento para o tratamento de doença do olho anterior que compreende rebamipida e um agente de retenção de lágrima | |
| BR112013026257A2 (pt) | derivados de glicosídeo e usos dos mesmos para o tratamento de diabetes | |
| WO2013085849A3 (en) | Sulfate esters of noribogaine | |
| BR112014027884A2 (pt) | combinações farmacêuticas para tratamento de distúrbios metabólicos | |
| BR112013033831A2 (pt) | composição farmacêutica oftalmológica tópica que contém regorafenib | |
| BR112014002885A2 (pt) | uso de composto orgânico para o tratamento da síndrome de noonan | |
| BR112012020377A8 (pt) | utilização de um ou mais selecionado do grupo constituído por um composto da fórmula (i), uma mistura racêmica-diastereomérica e um isômero óptico do referido composto, e um sal farmaceuticamente aceitável e uma pródroga do mesmo, método, composição farmacêutica e kit para tratamento de caquexia e embalagem comercial |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] | ||
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |